Jun 28, 2021
1:15
For every 15 shares held, investors received 1. The price per share adjusted from $0.07 to $0.00.
The split itself did not change the total investment value.
Millendo Therapeutics, Inc. (MLND) trades on the NASDAQ Capital Market in the Biotechnology industry.
Millendo Therapeutics, Inc. company overviewThe latest split shown was on June 28, 2021. It was a 1-for-15 reverse split, so shareholders received 1 share for every 15 they held.
This history records 2 reverse splits between December 10, 2018 and June 28, 2021.